Unknown

Dataset Information

0

Adoptive immunotherapy for cancer: harnessing the T cell response.


ABSTRACT: Immunotherapy based on the adoptive transfer of naturally occurring or gene-engineered T cells can mediate tumour regression in patients with metastatic cancer. Here, we discuss progress in the use of adoptively transferred T cells, focusing on how they can mediate tumour cell eradication. Recent advances include more accurate targeting of antigens expressed by tumours and the associated vasculature, and the successful use of gene engineering to re-target T cells before their transfer into the patient. We also describe how new research has helped to identify the particular T cell subsets that can most effectively promote tumour eradication.

SUBMITTER: Restifo NP 

PROVIDER: S-EPMC6292222 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adoptive immunotherapy for cancer: harnessing the T cell response.

Restifo Nicholas P NP   Dudley Mark E ME   Rosenberg Steven A SA  

Nature reviews. Immunology 20120322 4


Immunotherapy based on the adoptive transfer of naturally occurring or gene-engineered T cells can mediate tumour regression in patients with metastatic cancer. Here, we discuss progress in the use of adoptively transferred T cells, focusing on how they can mediate tumour cell eradication. Recent advances include more accurate targeting of antigens expressed by tumours and the associated vasculature, and the successful use of gene engineering to re-target T cells before their transfer into the p  ...[more]

Similar Datasets

| S-EPMC2773493 | biostudies-literature
| S-EPMC8161860 | biostudies-literature
| S-EPMC1131930 | biostudies-literature
| S-EPMC4869278 | biostudies-literature
| S-EPMC7612108 | biostudies-literature
| S-EPMC5709224 | biostudies-literature
| S-EPMC8714942 | biostudies-literature
| S-EPMC8390258 | biostudies-literature
| S-EPMC3716460 | biostudies-literature
| S-EPMC8477924 | biostudies-literature